CD163 and kidney disorder: Also, urinary soluble CD163 may be used as an indicator of response to treatment [6,12,86,160], as suggested in one study conducted by Mejia-Vilet, where a urinary soluble CD163 value of <370 ng/mmol at month 6 predicted CRR at month 12 with a Sn of 90% and a Sp of 87%, outperforming conventional kidney disease-related and immuno-serological biomarkers [6].